Pharma Times
DECEMBER 9, 2021
In a new report from The Institute of Cancer Research (ICR), data from cancer trials alongside assessments from clinicians and patients aims to provide guidance on how to improve services
Outsourcing Pharma
DECEMBER 7, 2021
According to a leader from Cytoreason, AI isnât necessarily the best or only tool suited to discover new and novel therapiesâit might take a human touch.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
DECEMBER 6, 2021
Pear Therapeutics has completed its merger with blank cheque company Thimble Point Acquisition Corp, claiming a Nasdaq listing and raising $175 million in gross proceeds for the digital health specialist. Pear will make its debut on the exchange today after combining with Thimble Point – a special purpose acquisition company (SPAC) – in a deal that sidestepped the conventional initial public offering (IPO) route and has propelled its valuation to around $1.6 billion.
NY Times
DECEMBER 5, 2021
Powerful associates of Syria’s president, Bashar al-Assad, are making and selling captagon, an illegal amphetamine, creating a new narcostate on the Mediterranean.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pharma Times
DECEMBER 8, 2021
A senior official at the World Health Organisation (WHO) has said that Omicron is ‘highly unlikely’ to fully bypass vaccine protections.
Outsourcing Pharma
DECEMBER 6, 2021
The organizations have issued an in-depth look on issues impacting inclusivity, why change is needed, and potential solutions for increasing trial diversity.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
NY Times
DECEMBER 8, 2021
The antibody drug, Evusheld, was found to be strongly effective in preventing Covid in a clinical trial that enrolled mostly those at high risk.
Pharma Times
DECEMBER 7, 2021
According to clinical data, Roche’s new COVID-19 treatment Actemra/RoActemra lowered mortality risk in critically ill adult patients.
Drug Patent Watch
DECEMBER 8, 2021
This chart shows the drugs with the most patents in Eurasian Patent Organization. Patents must be filed in each country (or, in some cases regional patent office) where patent protection…. The post Which pharmaceutical drugs have the most drug patents in Eurasian Patent Organization? appeared first on DrugPatentWatch - Make Better Decisions.
pharmaphorum
DECEMBER 6, 2021
UK artificial intelligence specialist BenevolentAI has said it will float on the Amsterdam Euronext exchange in what is being touted as Europe’s largest ever special purpose acquisition company (SPAC) deal. BenevolentAI will merge with Odyssey Acquisition, a SPAC set up by investment bankers Michael and Yoel Zaoui that lists former Sanofi chief executive Olivier Brandicourt among its advisors – in a deal that will raise some €390 million in proceeds.
Advertisement
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
NY Times
DECEMBER 4, 2021
Scientists in a cutting-edge laboratory do part of the work. Local health workers on foot do the rest.
Pharma Times
DECEMBER 6, 2021
GP practices can now postpone minor surgery and routine health checks for over-75s and new patients until 31 March 2022 to ensure booster jabs are rapidly and effectively delivered.
Drug Patent Watch
DECEMBER 9, 2021
This chart shows the pharmaceutical companies with the most concentrate dosed drugs. For a different perspective, see the most popular dosage types. The companies with the most concentrate dosed drugs…. The post Which pharmaceutical companies have the most concentrate dosed drugs? appeared first on DrugPatentWatch - Make Better Decisions.
pharmaphorum
DECEMBER 9, 2021
Heather Barnes, external innovation lead EMEA at Johnson and Johnson Consumer Health, is a scientist who is truly passionate about consumer health. With her background in biochemistry and eye for identifying innovation trends, the future is bright at Johnson & Johnson Innovation. After making her way from early-stage drug development research to her current role, Heather got straight to work on creating sustainable collaborations that made life better for people and their families.
Speaker: Joe Sharpe and James Carlson
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
NY Times
DECEMBER 7, 2021
Merck and Pfizer will soon debut prescription pills to treat Covid-19. And more drugs are on the way.
Pharma Times
DECEMBER 9, 2021
The drug is additionally undergoing assessment with the Medicines and Healthcare products Regulatory Agency for a marketing authorisation in the UK
Drug Patent Watch
DECEMBER 9, 2021
Annual Drug Patent Expirations for PROAIR+RESPICLICK Proair Respiclick is a drug marketed by Teva Branded Pharm and is included in one NDA. It is available from two suppliers. There are…. The post New patent for Teva Branded drug PROAIR RESPICLICK appeared first on DrugPatentWatch - Make Better Decisions.
pharmaphorum
DECEMBER 7, 2021
Since the onset of the Covid-19 pandemic, life science companies have acted quickly to address the evolving digital needs of healthcare professionals, with mixed success (see graph 1). In the age of information overload, we all know that it is essential to add ‘value’ if we are to cut through the noise. And therein lies an issue. In a recent study by EPG Health, pharma respondents voted ‘providing real value’ the top challenge (of 23) related to digital Health Care Provider (HCP) engagement.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Drug Channels
DECEMBER 7, 2021
It’s time for our annual deep dive into employer-sponsored coverage for prescription drugs. For 2021, employers backed away slightly from high-deductible health plans. However, their pharmacy benefit designs increased the use of coinsurance for specialty and fourth-tier drugs. These designs have significantly raised patients’ out-of-pocket obligations and are likely to have reduced adherence.
Pharma Times
DECEMBER 6, 2021
With the emergence of the new Omicron variant bringing into question the effectiveness of current vaccines, scientists caution that viruses will continue to evolve.
Drug Patent Watch
DECEMBER 6, 2021
This chart shows the pharmaceutical companies with the most cream dosed drugs. For a different perspective, see the most popular dosage types. The companies with the most cream dosed drugs…. The post Which pharmaceutical companies have the most cream dosed drugs? appeared first on DrugPatentWatch - Make Better Decisions.
pharmaphorum
DECEMBER 8, 2021
Preliminary study results from South Africa have suggested that antibodies stimulated by Pfizer and BioNTech’s Comirnaty are less effective against the new COVID-19 variant Omicron. A study by the African Health Research Institute (AHRI) has found that the less of immune protection was “extensive but incomplete,” meaning that some level of immunity was retained against the vaccine.
Advertisement
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
Drug Channels
DECEMBER 5, 2021
Better Data, Better Outcomes: A LexisNexis ® Risk Solutions and Q1 Productions Webinar. December 14, 2021 1:00 pm ET. This webinar is scheduled for a 45 minute presentation followed by 10 to 15 minutes of Q&A. Click here to register for this complimentary webinar. Your business depends on the data collected everyday across healthcare. That data not only drives the validation of the products and services your company offers today, but it also generates opportunities for new products and servi
Pharma Times
DECEMBER 7, 2021
Results show support in favour of heterologous dosing which may help to advance vaccination programmes in poorer countries.
NY Times
DECEMBER 7, 2021
Prosecutors have shown personal documents like text messages and notes that Ms. Holmes wrote and have emphasized that she was ultimately responsible for the problems at Theranos.
pharmaphorum
DECEMBER 8, 2021
French digital health startup HypnoVR has completed a first-round financing, raising €4.5 million ($5.1 million) that will be used to roll out its virtual reality-based hypnosis therapies. The company has developed a an individually tailored immersive VR platform that it uses to deliver clinical hypnosis techniques to alleviate chronic pain, anxiety and discomfort during medical procedures like surgery.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Outsourcing Pharma
DECEMBER 8, 2021
Sited in Pennsylvania, the excipients specialistâs new facility reportedly will work toward advancing drug delivery research and boosting speed to market.
Pharma Times
DECEMBER 8, 2021
The Evra hormonal patch can be worn discreetly and according to Gedeon Richter UK Ltd, is over 99% effective at pregnancy prevention
Pharma Marketing Network
DECEMBER 10, 2021
Rita Ribeiro, Product Director, Oncology Marketing, is a marketing leader with 20 years of global and US healthcare experience in pharmaceutical, medical device and services organizations. She has developed and implemented regionalized, integrated strategic plans to increase brand awareness and drive organizational growth across multiple therapeutic areas and service networks.
pharmaphorum
DECEMBER 8, 2021
China’s Shanghai Henlius Biotech says its experimental PD-1 inhibitor serplulimab has extended survival when added to chemotherapy in a phase 3 trial as first-line therapy for extensive stage small cell lung cancer (ES-SCLC), setting up regulatory filings. The trial compared serplulimab (formerly HLX10) plus carboplatin and etoposide chemotherapy in previously untreated patients with ES-SCLC , and showed a higher overall survival than chemo alone, according to the company.
Drug Patent Watch
DECEMBER 9, 2021
Annual Drug Patent Expirations for PROAIR+DIGIHALER Proair Digihaler is a drug marketed by Teva Branded Pharm and is included in one NDA. It is available from two suppliers. There are…. The post New patent for Teva Branded drug PROAIR DIGIHALER appeared first on DrugPatentWatch - Make Better Decisions.
Expert insights. Personalized for you.
132 
Let's personalize your content